Müller J - Search Results

1

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

Minner S, Enodien M, Sirma H, Luebke AM, Krohn A, Mayer PS, Simon R, Tennstedt P, Müller J, Scholz L, Brase JC, Liu AY, Schlüter H, Pantel K, Schumacher U, Bokemeyer C, Steuber T, Graefen M, Sauter G, Schlomm T. Minner S, et al. Among authors: muller j. Clin Cancer Res. 2011 Sep 15;17(18):5878-88. doi: 10.1158/1078-0432.CCR-11-1251. Epub 2011 Jul 26. Clin Cancer Res. 2011. PMID: 21791629

2

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

Müller J, Ehlers A, Burkhardt L, Sirma H, Steuber T, Graefen M, Sauter G, Minner S, Simon R, Schlomm T, Michl U. Müller J, et al. Int J Cancer. 2013 Mar 15;132(6):1333-40. doi: 10.1002/ijc.27768. Epub 2012 Aug 30. Int J Cancer. 2013. PMID: 22886792 Free article.

3

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse.

Hennigs JK, Müller J, Adam M, Spin JM, Riedel E, Graefen M, Bokemeyer C, Sauter G, Huland H, Schlomm T, Minner S. Hennigs JK, et al. Among authors: muller j. PLoS One. 2014 Jul 10;9(7):e100469. doi: 10.1371/journal.pone.0100469. eCollection 2014. PLoS One. 2014. PMID: 25010045 Free PMC article.

4

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).

Hötzel J, Melling N, Müller J, Polonski A, Wolters-Eisfeld G, Izbicki JR, Karstens KF, Tachezy M. Hötzel J, et al. Among authors: muller j. J Cancer Res Clin Oncol. 2019 Sep;145(9):2285-2292. doi: 10.1007/s00432-019-02989-x. Epub 2019 Aug 1. J Cancer Res Clin Oncol. 2019. PMID: 31372722

5

Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.

Mandic R, Schamberger CJ, Müller JF, Geyer M, Zhu L, Carey TE, Grénman R, Dünne AA, Werner JA. Mandic R, et al. Among authors: muller jf. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6845-52. doi: 10.1158/1078-0432.CCR-05-0378. Clin Cancer Res. 2005. PMID: 16203773

6

Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?

Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki JR, Bockhorn M. Tachezy M, et al. Among authors: muller j. Stem Cells. 2014 Jun;32(6):1429-36. doi: 10.1002/stem.1665. Stem Cells. 2014. PMID: 24501004

7

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

Watermann I, Schmitt B, Stellmacher F, Müller J, Gaber R, Kugler Ch, Reinmuth N, Huber RM, Thomas M, Zabel P, Rabe KF, Jonigk D, Warth A, Vollmer E, Reck M, Goldmann T. Watermann I, et al. Among authors: muller j. Diagn Pathol. 2015 Jul 28;10:130. doi: 10.1186/s13000-015-0362-5. Diagn Pathol. 2015. PMID: 26215852 Free PMC article.

8

Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema.

Eggers LF, Müller J, Marella C, Scholz V, Watz H, Kugler C, Rabe KF, Goldmann T, Schwudke D. Eggers LF, et al. Among authors: muller j. Sci Rep. 2017 Sep 11;7(1):11087. doi: 10.1038/s41598-017-11339-1. Sci Rep. 2017. PMID: 28894173 Free PMC article.

9

Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.

Krönig H, Hofer K, Conrad H, Guilaume P, Müller J, Schiemann M, Lennerz V, Cosma A, Peschel C, Busch DH, Romero P, Bernhard H. Krönig H, et al. Among authors: muller j. Int J Cancer. 2009 Aug 1;125(3):649-55. doi: 10.1002/ijc.24414. Int J Cancer. 2009. PMID: 19444908 Free article.

10

DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer.

Goldmann T, Schmitt B, Müller J, Kröger M, Scheufele S, Marwitz S, Nitschkowski D, Schneider MA, Meister M, Muley T, Thomas M, Kugler C, Rabe KF, Siebert R, Reck M, Ammerpohl O. Goldmann T, et al. Among authors: muller j. Clin Epigenetics. 2021 Feb 17;13(1):38. doi: 10.1186/s13148-021-01024-6. Clin Epigenetics. 2021. PMID: 33596996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,802 results

Search Page